147 related articles for article (PubMed ID: 10846774)
1. Combined ultrasound biometry, serum markers and age for Down syndrome risk estimation.
Bahado-Singh RO; Oz AU; Gomez K; Hunter D; Copel J; Baumgarten A; Mahoney MJ
Ultrasound Obstet Gynecol; 2000 Mar; 15(3):199-204. PubMed ID: 10846774
[TBL] [Abstract][Full Text] [Related]
2. Maternal serum screening for fetal Down syndrome in women less than 35 years of age using alpha-fetoprotein, hCG, and unconjugated estriol: a prospective 2-year study.
Phillips OP; Elias S; Shulman LP; Andersen RN; Morgan CD; Simpson JL
Obstet Gynecol; 1992 Sep; 80(3 Pt 1):353-8. PubMed ID: 1379701
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of combining maternal serum alpha-fetoprotein and hCG in a second-trimester screening program for Down syndrome.
Mooney RA; Peterson CJ; French CA; Saller DN; Arvan DA
Obstet Gynecol; 1994 Aug; 84(2):298-303. PubMed ID: 7518896
[TBL] [Abstract][Full Text] [Related]
4. A prospective evaluation of a second-trimester screening test for fetal Down syndrome using maternal serum alpha-fetoprotein, hCG, and unconjugated estriol.
Cheng EY; Luthy DA; Zebelman AM; Williams MA; Lieppman RE; Hickok DE
Obstet Gynecol; 1993 Jan; 81(1):72-7. PubMed ID: 7677967
[TBL] [Abstract][Full Text] [Related]
5. New triple screen test for Down syndrome: combined urine analytes and serum AFP.
Bahado-Singh RO; Oz U; Kovanci E; Cermik D; Flores D; Copel J; Mahoney M; Cole L
J Matern Fetal Med; 1998; 7(3):111-4. PubMed ID: 9642606
[TBL] [Abstract][Full Text] [Related]
6. Prenatal screening for Down's syndrome using inhibin-A as a serum marker.
Wald NJ; Densem JW; George L; Muttukrishna S; Knight PG
Prenat Diagn; 1996 Feb; 16(2):143-53. PubMed ID: 8650125
[TBL] [Abstract][Full Text] [Related]
7. Serum triple-marker screening in in vitro fertilization and naturally conceived pregnancies.
Frishman GN; Canick JA; Hogan JW; Hackett RJ; Kellner LH; Saller DN
Obstet Gynecol; 1997 Jul; 90(1):98-101. PubMed ID: 9207822
[TBL] [Abstract][Full Text] [Related]
8. Sensitivity and specificity of screening for Down syndrome with alpha-fetoprotein, hCG, unconjugated estriol, and maternal age.
MacDonald ML; Wagner RM; Slotnick RN
Obstet Gynecol; 1991 Jan; 77(1):63-8. PubMed ID: 1701526
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of trisomy 21 risk by serial determination of chorionic gonadotrophin hormone and alpha-fetoprotein: results of a national pilot study].
Aymé S; Aurran Y; Chabal F; Gombert A; Loundou H; Montfort C; Sollier M; Silvestri A
Contracept Fertil Sex; 1993 Feb; 21(2):133-43. PubMed ID: 7524931
[TBL] [Abstract][Full Text] [Related]
10. Second-trimester maternal serum CA-125 versus estriol in the multiple-marker screening test for Down syndrome.
Wenstrom KD; Owen J; Boots L
Obstet Gynecol; 1997 Mar; 89(3):359-63. PubMed ID: 9052585
[TBL] [Abstract][Full Text] [Related]
11. [Prenatal serum screening of aneuploidy and of neural tube defects in the second trimester of pregnancy among the population of Luxembourg. Evaluation of risk by the triple test (AFP+THCG+UE3)].
Thix J
Bull Soc Sci Med Grand Duche Luxemb; 1997; 134(1):25-9. PubMed ID: 9303823
[TBL] [Abstract][Full Text] [Related]
12. Maternal serum screening of fetal chromosomal abnormalities by AFP, UE3, hCG and free-beta hCG. Prospective and retrospective results.
Valerio D; Aiello R; Altieri V; Fagnoni P
Minerva Ginecol; 1996 May; 48(5):169-73. PubMed ID: 8783867
[TBL] [Abstract][Full Text] [Related]
13. Multiple marker screening for Down syndrome in twin pregnancies.
Neveux LM; Palomaki GE; Knight GJ; Haddow JE
Prenat Diagn; 1996 Jan; 16(1):29-34. PubMed ID: 8821849
[TBL] [Abstract][Full Text] [Related]
14. Inclusion of serum marker measurements from a previous pregnancy improves Down syndrome screening performance.
Larsen SO; Christiansen M; Nørgaard-Pedersen B
Prenat Diagn; 1998 Jul; 18(7):706-12. PubMed ID: 9706652
[TBL] [Abstract][Full Text] [Related]
15. AFP and age screening for Down syndrome.
Wald N; Cuckle H
Am J Med Genet; 1988 Sep; 31(1):197-209. PubMed ID: 2464930
[TBL] [Abstract][Full Text] [Related]
16. Age-specific detection and false-positive rates: an aid to counseling in Down syndrome risk screening.
Reynolds TM; Nix AB; Dunstan FD; Dawson AJ
Obstet Gynecol; 1993 Mar; 81(3):447-50. PubMed ID: 7679788
[TBL] [Abstract][Full Text] [Related]
17. Fetal biometry as a screening tool for the detection of chromosomally abnormal pregnancies.
Dicke JM; Gray DL; Songster GS; Crane JP
Obstet Gynecol; 1989 Nov; 74(5):726-9. PubMed ID: 2530480
[TBL] [Abstract][Full Text] [Related]
18. Down syndrome prevention program in a population with an older maternal age.
Shohat M; Legum C; Romem Y; Borochowitz Z; Bach G; Goldman B
Obstet Gynecol; 1995 Mar; 85(3):368-73. PubMed ID: 7862374
[TBL] [Abstract][Full Text] [Related]
19. The Influence of Maternal Weight Correction Formulas in Asian Down Syndrome Screening Using alpha-Fetoprotein and Free beta-Human Chorionic Gonadotropin.
Hsu JJ; Hsieh TT; Soong YK; Kuo B
J Matern Fetal Investig; 1998 Jun; 8(2):66-70. PubMed ID: 9685559
[TBL] [Abstract][Full Text] [Related]
20. Normal nuchal thickness in the midtrimester indicates reduced risk of Down syndrome in pregnancies with abnormal triple-screen results.
Bahado-Singh RO; Goldstein I; Uerpairojkit B; Copel JA; Mahoney MJ; Baumgarten A
Am J Obstet Gynecol; 1995 Oct; 173(4):1106-10. PubMed ID: 7485301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
